'Too much of a good thing': can network meta-analysis guide treatment decision-making in psoriatic arthritis?

Helena Marzo-Ortega^{1

2}, Jon Packham^{3

4}, Mar Pujades-Rodriguez^{5

6}

Affiliations

¹ NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust.
² Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds.
³ Haywood Rheumatology Centre, Stoke on Trent.
⁴ Division of Public Health and Epidemiology, University of Nottingham.
⁵ Real World Solution, IQVIA, London.
⁶ Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.

Editorial

Helena Marzo-Ortega et al. Rheumatology (Oxford). 2021.

. 2021 Jul 1;60(7):3042-3044.

doi: 10.1093/rheumatology/keab329.

Helena Marzo-Ortega^{1

2}, Jon Packham^{3

4}, Mar Pujades-Rodriguez^{5

6}

¹ NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust.
² Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds.
³ Haywood Rheumatology Centre, Stoke on Trent.
⁴ Division of Public Health and Epidemiology, University of Nottingham.
⁵ Real World Solution, IQVIA, London.
⁶ Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.

No abstract available

Comment on

Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis.
Mease PJ, McInnes IB, Tam LS, Eaton K, Peterson S, Schubert A, Chakravarty SD, Parackal A, Karyekar CS, Nair S, Boehncke WH, Ritchlin C. Mease PJ, et al. Rheumatology (Oxford). 2021 May 14;60(5):2109-2121. doi: 10.1093/rheumatology/keab119. Rheumatology (Oxford). 2021. PMID: 33844022 Free PMC article.